Page last updated: 2024-09-05

sorafenib and nsc 664704

sorafenib has been researched along with nsc 664704 in 3 studies

Compound Research Comparison

Studies
(sorafenib)
Trials
(sorafenib)
Recent Studies (post-2010)
(sorafenib)
Studies
(nsc 664704)
Trials
(nsc 664704)
Recent Studies (post-2010) (nsc 664704)
6,5207305,25195050

Protein Interaction Comparison

ProteinTaxonomysorafenib (IC50)nsc 664704 (IC50)
nuclear receptor subfamily 0 group B member 1Homo sapiens (human)0.8335
Cyclin-T1Homo sapiens (human)0.064
G2/mitotic-specific cyclin-B2Homo sapiens (human)0.4
Tyrosine-protein kinase LckHomo sapiens (human)0.47
Cyclin-dependent kinase 1Homo sapiens (human)0.4
Replicase polyprotein 1abSevere acute respiratory syndrome coronavirus 21.5
G2/mitotic-specific cyclin-B1Homo sapiens (human)0.4
G2/mitotic-specific cyclin-BMarthasterias glacialis (spiny starfish)0.4243
Alpha-1B adrenergic receptorRattus norvegicus (Norway rat)0.064
Glycogen synthase kinase-3 betaRattus norvegicus (Norway rat)0.4243
Cyclin-A2Homo sapiens (human)0.73
Alpha-1D adrenergic receptorRattus norvegicus (Norway rat)0.064
Cyclin-dependent kinase 2Homo sapiens (human)0.73
Mitogen-activated protein kinase 1Homo sapiens (human)9
Alpha-1A adrenergic receptorRattus norvegicus (Norway rat)0.064
Glycogen synthase kinase-3 alphaHomo sapiens (human)0.023
Glycogen synthase kinase-3 betaHomo sapiens (human)0.0657
Cyclin-dependent kinase 9Homo sapiens (human)0.064
Cyclin-A1Homo sapiens (human)0.73
Cyclin-dependent-like kinase 5 Homo sapiens (human)0.6314
Cyclin-dependent kinase 5 activator 1Homo sapiens (human)0.6314
G2/mitotic-specific cyclin-B3Homo sapiens (human)0.4
Cyclin-dependent kinase 1Oryzias latipes (Japanese medaka)0.4243

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (33.33)29.6817
2010's1 (33.33)24.3611
2020's1 (33.33)2.80

Authors

AuthorsStudies
Alessi, DR; Arthur, JS; Bain, J; Cohen, P; Elliott, M; Hastie, CJ; Klevernic, I; McLauchlan, H; Plater, L; Shpiro, N1
Hajduk, PJ; Johnson, EF; Kifle, L; Merta, PJ; Metz, JT; Soni, NB1
Laufer, S; Pillaiyar, T1

Reviews

1 review(s) available for sorafenib and nsc 664704

ArticleYear
Kinases as Potential Therapeutic Targets for Anti-coronaviral Therapy.
    Journal of medicinal chemistry, 2022, 01-27, Volume: 65, Issue:2

    Topics: Antiviral Agents; COVID-19; COVID-19 Drug Treatment; Humans; Protein Kinase Inhibitors; SARS-CoV-2; Signal Transduction; Virus Replication

2022

Other Studies

2 other study(ies) available for sorafenib and nsc 664704

ArticleYear
The selectivity of protein kinase inhibitors: a further update.
    The Biochemical journal, 2007, Dec-15, Volume: 408, Issue:3

    Topics: Amino Acid Sequence; Animals; Cell Line; Drug Design; Enzyme Activation; Humans; Mitogen-Activated Protein Kinases; Phosphorylation; Protein Kinase Inhibitors; Recombinant Proteins; Spodoptera

2007
Navigating the kinome.
    Nature chemical biology, 2011, Volume: 7, Issue:4

    Topics: Drug Design; Pharmacogenetics; Protein Kinases; Proteome; Systems Biology

2011